Keytruda (pembrolizumab) FDA Approval History | 合法藥品大搜索

have disease progression on FDA-approved therapy for these aberrations prior to receiving KEYTRUDA. (1.2, 2.1). Small Cell Lung Cancer (SCLC). Read More

have disease progression on FDA-approved therapy for these aberrations prior to receiving KEYTRUDA. (1.2, 2.1). Small Cell Lung Cancer (SCLC). • for the ... Read More

2021年5月12日 — FDA approval history for Keytruda (pembrolizumab) used to treat Melanoma, Metastatic, Non-Small Cell Lung Cancer, Head and Neck Cancer, ... Read More

FDA approves pembrolizumab for esophageal or GEJ carcinoma. Share · Tweet · Linkedin ... On March 22, 2021, the Food and Drug Administration approved ... Read More

2021年4月5日 — Today we'll be providing another quick update on a recent FDA cancer drug approval. On March 22, 2021, the FDA approved pembrolizumab ( ... Read More

On April 28, 2020, the Food and Drug Administration granted accelerated approval to a new dosing regimen of 400 mg every six weeks for pembrolizumab​ ... Read More

FDA-Approved Indications · It may be used when your melanoma has spread or cannot be removed by surgery (advanced melanoma), or · It may be used to help​ ... Read More

2021年3月23日 — FDA Approves Merck's KEYTRUDA Plus Chemotherapy for Treatment of Certain Patients With Locally Advanced or Metastatic Esophageal or ... Read More